2. Agenda
What is Plasmapheresis ?
INDICATIONS FOR PLASMAPHERESIS
TECHNIQUES
Replacement fluid
Vascular access
Anticoagulation
Regimens of PE
Complications
10. TECHNIQUES
A: Centrifugal plasma separation : blood cells
are separated during centrifugation , there
are two centrifugation methods Intermittent
flow device and continuous flow device
B: membrane plasma separation : plasma
separators use membranes with a molecular
weight 3 million
11.
12.
13.
14.
15. membrane plasma separation
Uses highly permeable hollow fibers with membrane pores
of 0.2to 0.5 µm.
The hollow fiber functions as a membrane, with the pore
size (0.2to 0.5 µm) allowing transport of plasma across the
membrane while retaining other blood components.
PlasmaFlux filters contain the polysulfone-based
Plasmasulfone membrane, which has been designed to
minimise the activation of the patient’s immune system
during blood–-membrane interaction
19. Electrolytes
Calcium:
10 ml of calcium gluconate solution per liter
of replacement solution
Potassium :
4 mmol of Potassium to each liter of
replacement solution
20. Vascular access
Standard central venous catheters
Arteriovenous(AV) fistula
Peripheral access through large-bore, short,
intravenous cannulae
21. Anticoagulation
1 - Citrate
IT is used for centrifugal plasma exchang.
citrate has particular advantages in patients at higher
bleeding risk in view of its lack of systemic anticoagulant
actions.
Citrate is rapidly metabolized by the liver (normal levels
within 4 hours).
Hepatic dysfunction severe hypocalcemia⇒
22. 2–Heparin
Used for membrane plasma filtration
Higher doses may be needed than in hemodialysis as a
result of increased losses during the procedure (heparin
is protein bound).
Bolus doses of unfractionated heparin 2000 to 5000 U
are given initially, and then 500 to 2000 U/h.
25. Frequancy of procedures
1- Daily plasma exchange
Most effective in rapidly depleting total body load.
Intensity of exchanges has no major effect on
outcomes except in hemolytic-uremic syndrome.
2- Alternate-day exchanges
proven efficacy in antineutrophil cytoplasmic
antibody (ANCA)–associated diseases.
26.
27. A single plasma volume exchange will lower
plasma macromolecule levels by
approximately 60% .
Five exchanges during 5 to 10 days will clear
90% of the total body Immunoglobulin
Target molecule kinetics during therapeutic plasma exchange. (A) Theoretical relationship between an increasing plasma volume exchanged relative to the patient’s plasma volume during the TPE procedure, and the percentage decrease in the concentration of the target molecule under idealized conditions. (B) Similar figure showing removal of target molecule from the beginning (closed circles) to the end of each of three TPE procedures (open circles), now taking into account factors such as biosynthesis, catabolism, and compartmental equilibration. Adapted from Kaplan (1) and Samtleben et al. (2). TPE, therapeutic plasma exchange.